Anti-SARS-CoV-2-specific serological responses are a topic of ongoing evaluation studies. In the study presented here, the anti-SARS-CoV-2 surrogate neutralization assays by TECOmedical and DiaPROPH -Med were assessed in a head-to-head comparison with serum samples of individuals after vaccination as well as after previous infection with SARS-CoV-2. In case of discordant results, a cell culture-based neutralization assay was applied as a reference standard. The TECOmedical assay showed sensitivity and specificity of 100% and 61.3%, respectively, the DiaPROPH-Med assay 95.0% and 48.4%, respectively. As a side finding of the study, differences in the likelihood of expressing neutralizing antibodies could be shown for different exposition types. So, 60 of 81 (74.07%) of the samples with only one vaccination showed an expression of neutralizing antibodies in contrast to 85.71% (60 of 70 samples) of the samples with two vaccinations and 100% (40 of 40) of the samples from previously infected individuals. In conclusion, the both assays showed results similar to previous assessments. While the measured diagnostic accuracy of both assays requires further technical improvement of this diagnostic approach, as the calculated specificity values of 61.3% and 48.4%, respectively, appear acceptable for diagnostic use only in populations with a high percentage of positive subjects, but not at expectedly low positivity rates.
【저자키워드】 COVID-19, SARS-CoV-2, vaccination, serology, neutralization, test comparison, 【초록키워드】 neutralizing antibody, Neutralizing antibodies, diagnostic, anti-SARS-CoV-2, Population, specificity, Diagnostic accuracy, Accuracy, Sensitivity and specificity, Neutralization assay, Cell culture, Head-to-head comparison, expression, reference standard, serological response, Topic, serum samples, assessments, head, infected individuals, individual, positive, while, serum sample, approach, Cell, likelihood, shown, applied, calculated, subjects, expressing, infection with SARS-CoV-2, were assessed, 【제목키워드】 individual, surrogate, Sample,